WIB22: Hear from our 2022 Women in Bio­phar­ma R&D hon­orees, and catch our pan­el on em­pow­er­ing women

If we’ve learned any­thing from our an­nu­al Women in Bio­phar­ma R&D re­port over the last four years, it’s that there’s much to cel­e­brate.

We re­ceived more than 500 nom­i­na­tions this year high­light­ing ex­tra­or­di­nary women who are blaz­ing trails in drug de­vel­op­ment. While se­lect­ing just 20 hon­orees has be­come in­creas­ing­ly dif­fi­cult, we were thrilled to de­but this year’s group with you last week. They’re sci­en­tists, CEOs, re­searchers and more who have de­vel­oped new drugs for rare and life-threat­en­ing dis­eases, changed the way we think about com­mon con­di­tions such as mi­graine, and bro­ken bound­aries.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.